Using markov systems to plan stroke services

Studies in Computational Intelligence

Volumn 189, Issue , 2009, Pages 241-256

  Mcclean, Sally ^a   Garg, Lalit ^a   Barton, Maria ^a   Fullerton, Ken ^b   Millard, Peter ^c  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Markov decision models; Markov systems; Stroke services

Indexed keywords

EID: 62249118513     PISSN: 1860949X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-00179-6_15     Document Type: Article

References (21)

1. Chambers, M.G., Koch, P., Hutton, J.: Development of a decision analytic model of stroke care in the United States and in Europe. Value in Health 5(2), 82-87 (2002)
2. Curtis, L.: Unit costs of health and social care: Personal Social Services Research Unit (PSSRU), University of Kent, Canterbury (2007)
3. Ehlers, L., Anderson, G., Clauson, G.S.: Cost-effectiveness of intravenous thrombolysis with altephase within a 3 hour window after ischemic stroke. Stroke 38, 85-89 (2007)
4. Faddy, M.J., McClean, S.I.: Markov Chain Modelling for Geriatric Patient Care. Methods of Information in Medicine 44(3), 369-373 (2005)
5. Fagan, S., Morgenson, L., Petitta, A., Ward, R.E., Tilley, B.C., Marler, J.R., Levine, S.R., Broderick, J.P., Kwiatkowski, T.G., Frankel, M., Brott, T.G., Walker, M.D., The NINDS rt-PA Stroke Study Group: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 50, 883-890 (1998)
6. Field, M.C., Levine, S.R.: Clot-busting therapy helps stroke victims - but only if they get treatment in time. Neur. 64, E1-E2 (2005)
7. García-Moncó, J.C., Pinedo, A., Escalza, I., Ferreira, E., Foncea, N., Gómez-Beldarrain, M., Ruiz-Ojeda, J., Mateo, I., Mediavilla, J., Basterretxea, J.M.: Analysis of the reasons for the exclusion of tpa therapy after early arrival in hospital. Clinical Neurol. Neurosurg. (August 2006)
8. Hacke, W., Kaste, M., Fieschi, C.: Intravenous thrombolysis with recumbent tissue activator for acute hemi-spheric stroke. The European Acute Stroke Study (ECASS), JAMA 274, 1017-1022 (1995)
9. Jorgenson, H., Nakayama, H., Raaschou, H.: The effect of a stroke unit: Reduction in mortality, discharge rates to nursing homes, length of stay and cost - A community based study. Stroke 26, 1178-1182 (1995)
10. Leibson, C.: Stroke attributable nursing home use. A population based study. Neurology 51, 163-168 (1998)
11. McClean, S.I., Millard, P.H.: Where to Treat the Older Patient? Can Markov Models Help us Better Understand the Relationship between Hospital and Community Care? Journal of the Operational Research Society 58(2), 255-261 (2006)
12. McClean, S.I., Papadopoulou, A., Tsaklidis, G., Garg, L., Barton, M., Millard, P.: Evaluating strategies using non-homogeneous Markov and semi-Markov Systems. In: International Workshop on Applied Probability, Compiègne, France, July 7-10 (2008)
13. Marshall, A.H., McClean, S.I., Shapcott, C.M., Millard, P.H.: Learning dynamic bayesian belief networks using conditional phase-type distributions. In: Zighed, D.A., Komorowski, J., Zytkow, J.M. (eds.) PKDD 2000. LNCS, vol. 1910, pp. 516-523. Springer, Heidelberg (2000)
14. National Audit Office: Reducing brain damage: Faster access to better stroke care. Report by the controller and audit general, NAO. London (2005)
15. National Institute for Clinical Excellence (NICE): Final Appraisal Determination: Drugs for early thrombolysis in treatment of acute myocardial infarction. London, UK, National Institute for Clinical Excellence (2002)
16. National Institute of Neurological Disorders and Stroke (NINDS) and Tissue Plasiminogen activator (tpa) Stroke Study Group: Tissue plasminogen activator for acute stroke. New England Journal of Medicine 333(24), 1581-1587 (1995)
17. Sandercock, P., Berge, E., Dennis, M., Forbes, J., Hand, P., Kwan, J., Lewis, S., Neilson, A., Wardlaw, J.: Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke 35, 1490-1498 (2004)
18. Stahl, J.E., Furie, K.L., Gleason, S., Gazelle, G.S.: Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology 228, 659-668 (2003)
19. Sundberg, G., Bagust, A., Terent, A.: A model for costs of stroke services. Health Policy 63, 81-94 (1993)
20. Taylor, W.J., Wong, A., Siegert, R.J., McNaughton, H.K.: Effectiveness of a clinical pathway for acute stroke care in a district general hospital: An audit. BMC Health Services Research, BioMed. Central, 1-7 (2006)
21. Wardlaw, J.M., Zoppo, G., Yamaguchi, T., Berge, E.: Thrombolysis for acute ischemic stroke (Cochrane Review). The Cochrane Library. Cochrane Database System Rev. 3. Oxford (1993)